The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...

The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that could have broad consequences for generic drug makers and so-called "skinny ...

Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

Patients with limited English proficiency at UCHealth may have access to prescription medication labels in their primary language. UCHealth launched a program in February that translates prescription ...

A packaging mix-up has led to the recall of a blood pressure medication and a second medication designed to lower the risk of having a stroke or serious heart problems, the U.S. Food and Drug ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Medications are an important component of health care, but each year their misuse results in over a million adverse drug events that lead to office and emergency room visits as well as ...

Researchers looking at neonate drug label changes following recent legislation found only 46 percent of neonatal labeling changes indicated the safety and effectiveness of the drug, according to a ...